News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,410 Results
Type
Article (13831)
Company Profile (101)
Press Release (252478)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88076)
Career Advice (465)
Deals (15347)
Drug Delivery (67)
Drug Development (36607)
Employer Resources (49)
FDA (6301)
Job Trends (6204)
News (150270)
Policy (14047)
Tag
Academia (441)
Accelerated approval (2)
Adcomms (6)
Allergies (38)
Alliances (23244)
ALS (39)
Alzheimer's disease (394)
Antibody-drug conjugate (ADC) (46)
Approvals (6339)
Artificial intelligence (115)
Autoimmune disease (9)
Automation (4)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (22)
Brain cancer (16)
Breast cancer (83)
Cancer (653)
Cardiovascular disease (74)
Career advice (409)
Career pathing (12)
CAR-T (23)
Cell therapy (91)
Cervical cancer (4)
Clinical research (30973)
Collaboration (362)
Compensation (166)
Complete response letters (17)
COVID-19 (760)
CRISPR (23)
C-suite (133)
Cystic fibrosis (39)
Data (695)
Denatured (15)
Depression (10)
Diabetes (84)
Diagnostics (1327)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (61)
Drug pricing (68)
Drug shortages (12)
Duchenne muscular dystrophy (39)
Earnings (32363)
Editorial (14)
Employer branding (4)
Employer resources (43)
Events (37660)
Executive appointments (407)
FDA (6786)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (221)
Gene editing (41)
Generative AI (9)
Gene therapy (103)
GLP-1 (351)
Government (1305)
Grass and pollen (3)
Guidances (61)
Healthcare (3566)
Huntington's disease (4)
IgA nephropathy (12)
Immunology and inflammation (37)
Indications (14)
Infectious disease (795)
Inflammatory bowel disease (58)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (48)
Interviews (59)
IPO (5888)
IRA (29)
Job creations (2052)
Job search strategy (373)
Kidney cancer (6)
Labor market (14)
Layoffs (183)
Leadership (4)
Legal (3433)
Liver cancer (19)
Lung cancer (88)
Lymphoma (57)
Machine learning (4)
Management (16)
Manufacturing (172)
MASH (34)
Medical device (1278)
Medtech (1280)
Mergers & acquisitions (9677)
Metabolic disorders (269)
Multiple sclerosis (21)
NASH (14)
Neurodegenerative disease (25)
Neuropsychiatric disorders (8)
Neuroscience (587)
NextGen: Class of 2025 (1586)
Non-profit (595)
Now hiring (8)
Obesity (153)
Opinion (119)
Ovarian cancer (22)
Pain (58)
Pancreatic cancer (17)
Parkinson's disease (47)
Partnered (7)
Patents (127)
Patient recruitment (30)
Peanut (10)
People (29009)
Pharmaceutical (64)
Pharmacy benefit managers (12)
Phase I (8062)
Phase II (13105)
Phase III (11757)
Pipeline (536)
Policy (74)
Postmarket research (1401)
Preclinical (3237)
Press Release (25)
Prostate cancer (48)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (175)
Real estate (2637)
Recruiting (17)
Regulatory (10156)
Reports (14)
Research institute (566)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (38)
Series A (39)
Series B (15)
Service/supplier (3)
Sickle cell disease (32)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1629)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (37)
The Weekly (30)
Vaccines (159)
Venture capitalists (14)
Weight loss (100)
Women's health (8)
Worklife (4)
Date
Last 7 days (338)
Last 30 days (1007)
Last 365 days (11588)
2025 (4268)
2024 (12501)
2023 (14246)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14885)
2018 (11713)
2017 (13889)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (58)
Arkansas (3)
Asia (20170)
Australia (2618)
California (1854)
Canada (956)
China (255)
Colorado (72)
Connecticut (73)
Delaware (62)
Europe (39572)
Florida (357)
Georgia (40)
Idaho (9)
Illinois (206)
India (16)
Indiana (138)
Iowa (1)
Japan (101)
Kansas (60)
Kentucky (13)
Louisiana (2)
Maine (2)
Maryland (273)
Massachusetts (1600)
Michigan (30)
Minnesota (99)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (9)
New Hampshire (6)
New Jersey (812)
New Mexico (7)
New York (547)
North Carolina (409)
North Dakota (2)
Northern California (770)
Ohio (51)
Oklahoma (4)
Oregon (16)
Pennsylvania (475)
Puerto Rico (8)
Rhode Island (10)
South America (503)
South Carolina (3)
Southern California (778)
Tennessee (36)
Texas (247)
United States (7716)
Utah (36)
Virginia (81)
Washington D.C. (32)
Washington State (127)
Wisconsin (19)
266,410 Results for "kalvista pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
KalVista Pharmaceuticals to Present at the Citizens Life Sciences Conference
April 30, 2025
·
2 min read
Press Releases
KalVista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan
April 8, 2025
·
4 min read
Press Releases
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 2, 2025
May 2, 2025
·
1 min read
Press Releases
KalVista Pharmaceuticals to Present at 24th Annual Needham Virtual Healthcare Conference
March 31, 2025
·
2 min read
Press Releases
KalVista Pharmaceuticals Announces Early Completion of Enrollment in KONFIDENT-KID Pediatric HAE Trial
March 26, 2025
·
4 min read
Press Releases
KalVista Pharmaceuticals to Present at Upcoming March 2025 Investor Conferences
February 25, 2025
·
2 min read
Press Releases
KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update
March 12, 2025
·
8 min read
Press Releases
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 2, 2025
April 3, 2025
·
1 min read
Press Releases
KalVista Pharmaceuticals to Host Investor Webcast Highlighting Commercialization Strategy, Plans and Progress for Sebetralstat in Hereditary Angioedema
March 10, 2025
·
3 min read
Press Releases
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2025
March 5, 2025
·
1 min read
1 of 26,641
Next
